These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35241494)

  • 1. Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer.
    Bai Y; Xie T; Wang Z; Tong S; Zhao X; Zhao F; Cai J; Wei X; Peng Z; Shen L
    J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35241494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
    Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
    Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of Epstein-Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet chemotherapy.
    Kim EJ; Chae H; Park YS; Ryu MH; Kim HD; Shin J; Park YS; Moon MS; Kang YK
    Gastric Cancer; 2024 Jan; 27(1):146-154. PubMed ID: 38006567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer.
    Li X; Xiong F; Hu Z; Tao Q; Yang Y; Qiao X; Peng C; Jiang Y; Han M; Dong K; Hua Y; Zhang W; Xu M; Long W; Xiao Y; Wang D
    J Transl Med; 2024 Jan; 22(1):90. PubMed ID: 38254099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Landscape of Epstein-Barr Virus-Associated Gastric Cancer: Analysis From a Western Academic Institution.
    Yee EJ; Gilbert D; Kaplan J; van Dyk L; Kim SS; Berg L; Clambey E; Wani S; McCarter MD; Stewart CL
    J Surg Res; 2024 Apr; 296():742-750. PubMed ID: 38368775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review.
    Bos J; Groen-van Schooten TS; Brugman CP; Jamaludin FS; van Laarhoven HWM; Derks S
    Cancer Treat Rev; 2024 Jun; 127():102737. PubMed ID: 38669788
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Klümper N; Ralser DJ; Zarbl R; Schlack K; Schrader AJ; Rehlinghaus M; Hoffmann MJ; Niegisch G; Uhlig A; Trojan L; Steinestel J; Steinestel K; Wirtz RM; Sikic D; Eckstein M; Kristiansen G; Toma M; Hölzel M; Ritter M; Strieth S; Ellinger J; Dietrich D
    J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34446578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outlooks on Epstein-Barr virus associated gastric cancer.
    Naseem M; Barzi A; Brezden-Masley C; Puccini A; Berger MD; Tokunaga R; Battaglin F; Soni S; McSkane M; Zhang W; Lenz HJ
    Cancer Treat Rev; 2018 May; 66():15-22. PubMed ID: 29631196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-dependent different clinicopathological characterization of Epstein-Barr virus-associated gastric carcinoma: a large-scale study.
    Kim JH; Kim N; Song DH; Choi Y; Jeon EB; Kim S; Jun YK; Yoon H; Shin CM; Park YS; Lee DH; Oh HJ; Lee HS; Park YS; Ahn SH; Suh YS; Park DJ; Kim HH; Kim JW; Kim JW; Lee KW; Chang W; Park JH; Lee YJ; Lee KH; Kim YH; Ahn S
    Gastric Cancer; 2024 Mar; 27(2):221-234. PubMed ID: 38212543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region.
    Dias JM; Santana IVV; da Silva VD; Carvalho AL; Arantes LMRB
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Combination of Biomarkers Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer.
    Jiang Z; Zhou Y; Huang J
    Front Immunol; 2021; 12():813331. PubMed ID: 35003141
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Kong W; Liu X; Zhu H; Zheng S; Yin G; Yu P; Shan Y; Ma S; Ying R; Jin H
    Aging (Albany NY); 2024 Jan; 16(2):1767-1780. PubMed ID: 38244583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of PD-1 inhibitor-based first-line therapy in Chinese patients with metastatic gastric cancer: a retrospective real-world study.
    Duan Y; Li J; Zhou S; Bi F
    Front Immunol; 2024; 15():1370860. PubMed ID: 38933261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
    Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
    Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies.
    Yang RK; Qing Y; Jelloul FZ; Routbort MJ; Wang P; Shaw K; Zhang J; Lee J; Medeiros LJ; Kopetz S; Tetzlaff MT; Broaddus RR
    Oncotarget; 2020 Feb; 11(6):600-618. PubMed ID: 32110280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of Epstein-Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic Options.
    Re V; Brisotto G; Repetto O; De Zorzi M; Caggiari L; Zanussi S; Alessandrini L; Canzonieri V; Miolo G; Puglisi F; Belluco C; Steffan A; Cannizzaro R
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case report: A case of rare metastasis of gastric cancer to the axillary lymph node metastasis treated with combination immunotherapy.
    Wang J; Cheng Y; Wang Y; Liu H; Wu S; Tian G; Qu J; Qu X
    Front Immunol; 2024; 15():1331506. PubMed ID: 38404578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosis.
    He CY; Qiu MZ; Yang XH; Zhou DL; Ma JJ; Long YK; Ye ZL; Xu BH; Zhao Q; Jin Y; Lu SX; Wang ZQ; Guan WL; Zhao BW; Zhou ZW; Shao JY; Xu RH
    Clin Transl Med; 2020 Jan; 10(1):353-362. PubMed ID: 32508039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and pathological analyses of gastric stump cancer by next-generation sequencing and immunohistochemistry.
    Watanabe M; Kuwata T; Setsuda A; Tokunaga M; Kaito A; Sugita S; Tonouchi A; Kinoshita T; Nagino M
    Sci Rep; 2021 Feb; 11(1):4165. PubMed ID: 33603111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.